AstraZeneca
Alexion's Synthetic Product Development team is seeking a Ph.D. student for a 6-month co-op to develop a closed-loop computational and experimental platform for chiral ligand design. The role integrates state-of-the-art computational tools and experimental testing to accelerate catalyst development and optimization. This position offers hands-on experience applying computational chemistry and AI technologies to real-world challenges in diastereoselective catalyst design and ligand discovery.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
37% above the average for this role
Postdoctoral Fellow/Synthetic Chemist; Chemistry Zaleski Lab
Indiana University
Research Fellow (Asymmetric Transition Metal Catalysis)
Nanyang Technological University
Postdoctoral Research Associate Associate in Synthetic Chemistry
Oracle
Senior Engineer I, Computational Synthetic Chemist
Ginkgo Bioworks
Postdoctoral Fellow/Synthetic Chemist; Chemistry Zaleski Lab
Indiana University
Postdoctoral Researcher
Carnegie Mellon University